S095035
CL1-95035-001
Phase 2 small_molecule active
Quick answer
S095035 for MTAP-deleted Solid Tumors is a Phase 2 program (small_molecule) at Tango Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tango Therapeutics
- Indication
- MTAP-deleted Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active